Showing results (321-330 of 334) with videos related to
Sort By:
Pageof 34
Ebiomedicine|May 7, 2019
Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategiesAlberto Visioli, Fabrizio Giani, Nadia Trivieri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled AnalysisSara Gandini, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.Breast (Edinburgh, Scotland)|February 10, 2015
Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?Olivia Pagani, Monica Ruggeri, Silvia Manunta, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2014
Dose-response relationship in phase i clinical trials: a European Drug Development Network (EDDN) Collaboration StudyVictor Moreno García, David Olmos, Carlos Gomez-Roca, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2023
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 StudyMatteo Lazzeroni, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Patient selection for oncology phase I trials: a multi-institutional study of prognostic factorsDavid Olmos, Roger P A'hern, Silvia Marsoni, et al.Brain Sciences|September 28, 2024
Effectiveness of Transcranial Direct Current Stimulation (tDCS) during a Virtual Reality Task in Women with Fibromyalgia-A Randomized Clinical StudyThaís Nogueira da Silva, Vivian Finotti Ribeiro, Margot Carol Condori Apaza, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2025
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)L Malorni, S Tyekucheva, A Gombos, et al.Breast (Edinburgh, Scotland)|July 31, 2019
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European CentersM Ruggeri, E Pagan, V Bagnardi, et al.Nature Aging|June 25, 2024
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19Beatrice Dallan, Davide Proietto, Martina De Laurentis, et al.Pageof 34